Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Mersana Therapeutics
company
About
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $33M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$81M
Mersana Therapeutics has raised a total of
$81M
in funding over 2 rounds. Their latest funding was raised on
Jun 16, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 16, 2016 | Series C | $33M | 1 | — | — | Detail |
| Jul 31, 2012 | Series A | $27M | 1 | — | — | Detail |
| Nov 8, 2005 | Series Unknown | $21M | 2 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Mersana Therapeutics has made 1 investments. Their most recent investment was on
Nov 21, 2012, when biNu raised $4.30M.
Investors
Number of Lead Investors
Number of Investors
—
4
Mersana Therapeutics is funded by 4 investors.
Takeda
and Harris and Harris Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
— | Series C |
|
|
— | Series A |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
